Accordingly, in a Head and Neck Cancer (HNC) model, the maturation of DCs was promoted by Cetuximab-activated NK cells in the presence of tumor cells, and this effect was partially dependent on the IFN-γ produced by NK cells [44]. This evidence concerns the gene IFNG and head and neck cancer.